What Is Gabapentin?
Gabapentin (brand name Neurontin) is an anticonvulsant medication that has become one of the most commonly prescribed drugs for chronic pain, particularly nerve pain. While originally developed for epilepsy, it's now widely used for various pain conditions due to its effects on nerve signaling.1
Conditions Treated2
- Postherpetic neuralgia (FDA-approved)
- Diabetic neuropathy
- Fibromyalgia
- Peripheral neuropathy
- Chronic low back pain with nerve component
- Radiculopathy
- Many other nerve pain conditions
How It Works
- Binds to calcium channels in nerve cells
- Reduces release of excitatory neurotransmitters
- Calms overactive nerve signaling
- Not the same as traditional pain medications
Dosing3
- Start low (100-300 mg at bedtime)
- Gradually increase over days to weeks
- Typical dose: 300-1200 mg three times daily
- Maximum: 3600 mg/day (divided doses)
- Adjust for kidney function
Common Side Effects
- Drowsiness, dizziness
- Fatigue
- Difficulty concentrating
- Weight gain
- Peripheral edema (swelling)
- Blurred vision
Side Effects Often Improve
- Many side effects decrease over time
- Slow dose increases help
- Taking at bedtime can help with drowsiness
Important Warnings
- Don't stop suddenly—taper gradually
- May cause suicidal thoughts (rare)
- Respiratory depression risk with opioids
- Driving impairment possible
- Now a controlled substance in some states
Gabapentin vs. Pregabalin
- Same drug class
- Pregabalin may work faster
- Pregabalin has more linear absorption
- Gabapentin often tried first (less expensive)
- Some respond better to one than the other
Effectiveness
- Helps about 30-50% of patients significantly
- Partial relief in many others
- May take 2-8 weeks at adequate dose
- Give full trial before discontinuing
Drug Interactions
- Opioids (increased sedation, respiratory risk)
- Antacids (take gabapentin 2 hours after)
- Alcohol
- Other sedating medications
References
- Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD007938.
- Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology. 2002;59(5 Suppl 2):S14-S17.
- Bockbrader HN, Wesche D, Miller R, et al. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49(10):661-669.